Gerstein HC, Sattar N, Rosenstock J, Ramasundarahettige C, Pratley R, Lopes RD et al (2021) Cardiovascular and renal outcomes with efpeglenatide in type 2 diabetes
Frequently Asked Questions 1Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial New England Journal of Medicine, 2023 2 3Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) New England Journal of Medicine, 2022 4Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) New England Journal of Medicine, 2021 5Glucagon receptor agonism enhances energy expenditure in obese subjects Cell Metabolism, 2023 Related Articles Comparison Tirzepatide vs Semaglutide: Which Weight Loss Medication Works Better
If we want to know how to best use GLPs it is important to think about how we, as a society and as individuals, ended up in an obesity epidemic
Subsequently, the clusters were formed using cluster function